ClinConnect ClinConnect Logo
Search / Trial NCT00712608

The Evaluation of Cow's Milk Formula - Study B

Launched by MEAD JOHNSON NUTRITION · Jul 9, 2008

Trial Information

Current as of July 21, 2025

Completed

Keywords

Term Infant Formula

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Term infant
  • 12-16 days of age
  • 37-42 weeks GA
  • Exclusion Criteria:
  • History of chronic disease, congenital malformation
  • Feeding difficulties or formula intolerance
  • LGA

About Mead Johnson Nutrition

Mead Johnson Nutrition, a subsidiary of Reckitt Benckiser Group, is a leading global provider of pediatric nutrition products dedicated to advancing the health and well-being of infants and children. With a rich history spanning over a century, the company focuses on innovative research and development to create scientifically formulated nutritional solutions that support growth, development, and overall health. Committed to rigorous clinical trials and evidence-based practices, Mead Johnson Nutrition aims to enhance nutritional outcomes for children worldwide, ensuring that every child gets the best start in life.

Locations

Kingsport, Tennessee, United States

Lubbock, Texas, United States

Dallas, Texas, United States

Little Rock, Arkansas, United States

Norwich, Connecticut, United States

Little Rock, Arkansas, United States

Omaha, Nebraska, United States

Minot, North Dakota, United States

Longview, Texas, United States

Pittsburgh, Pennsylvania, United States

Benton, Arkansas, United States

Philadelphia, Pennsylvania, United States

Birmingham, Alabama, United States

Dothan, Alabama, United States

Fayetteville, Arkansas, United States

West Palm Beach, Florida, United States

Newburgh, Indiana, United States

Woburn, Massachusetts, United States

Niles, Michigan, United States

Stevensville, Michigan, United States

St. Paul, Minnesota, United States

Kingsport, Tennessee, United States

Patients applied

0 patients applied

Trial Officials

Carol L Berseth, MD

Study Director

Mead Johnson & Company

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials